Recent developments in neuronal nicotinic acetylcholine receptor modulators

Expert Opinion on Therapeutic Patents

Volumn 8, Issue 8, 1998, Pages 991-1015

  Lin, N H ^a   Meyer, M D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

ABT 089; ABT 418; ABT 594; Alzheimer's disease; Cholinergic channel activator; Epibatidine; GTS 21; nAChR; Neuronal nicotinic acetylcholine receptor; Parkinson's disease; RJR 2043; SIB 1765

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ANABASINE; ANABASINE DERIVATIVE; CYTISINE; EPIBATIDINE; METHYLCARBACHOL; NICOTINE DERIVATIVE; NICOTINIC AGENT; NICOTINIC RECEPTOR; PYRIDINE DERIVATIVE; RECEPTOR SUBTYPE;

ADDICTION; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; MODEL; PAIN; PARKINSON DISEASE; REVIEW;

EID: 0031904673     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.8.8.991     Document Type: Review

References (133)